Literature DB >> 7272940

Flow cytometry of breast carcinoma: I. Relation of DNA ploidy level to histology and estrogen receptor.

W Olszewski, Z Darzynkiewicz, P P Rosen, M K Schwartz, M R Melamed.   

Abstract

Flow cytometry studies of the DNA distribution of tumor cells from 92 human breast cancers showed measurable aneuploidy (hyperploidy) in 83 cases (92%). The DNA ploidy values were unimodal in each case, but there was a bimodal distribution for the entire series. One group of tumors had a diploid or near diploid DNA distribution and a second group had ploidy levels from triploid to tetraploid or higher. The tumors with lower DNA ploidy (at or near diploid) tended to be histologically low grade, cytologically more orderly and estrogen-binding positive; those with higher DNA ploidy were more likely to be higher grade, more anaplastic, and estrogen-binding negative.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7272940     DOI: 10.1002/1097-0142(19810815)48:4<980::aid-cncr2820480421>3.0.co;2-7

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  30 in total

1.  Comparison of extent of disease and morphometric and DNA flow cytometric prognostic factors in invasive ductal breast cancer.

Authors:  A M Uyterlinde; N W Schipper; J P Baak
Journal:  J Clin Pathol       Date:  1987-12       Impact factor: 3.411

2.  In vitro modulation of the metastatic phenotype. I. Analysis of differentiation forms of the B16 melanoma expressing Met-72 determinants and metastatic activity.

Authors:  J H Xiang; A K Kimura
Journal:  Clin Exp Metastasis       Date:  1986 Oct-Dec       Impact factor: 5.150

3.  DNA in human glioblastomas. A flow-fluorescence cytometrical examination of 96 tumors.

Authors:  F W Spaar; U Spaar
Journal:  Neurosurg Rev       Date:  1990       Impact factor: 3.042

4.  Flow cytometric DNA hypertetraploidy is associated with unfavourable prognostic features in breast cancer.

Authors:  A E Pinto; S André; M Nogueira; E Mendonça; J Soares
Journal:  J Clin Pathol       Date:  1997-07       Impact factor: 3.411

5.  Relationship of flow cytometry results to clinical and steroid receptor status in human breast cancer.

Authors:  T E Kute; H B Muss; M Hopkins; R Marshall; D Case; L Kammire
Journal:  Breast Cancer Res Treat       Date:  1985       Impact factor: 4.872

6.  Prognostic value of nuclear DNA content in breast cancer in relation to tumor size, nodal status, and estrogen receptor content.

Authors:  A von Rosen; L E Rutqvist; J Carstensen; A Fallenius; L Skoog; G Auer
Journal:  Breast Cancer Res Treat       Date:  1989-01       Impact factor: 4.872

Review 7.  Generation of phenotypic diversity and progression in metastatic tumor cells.

Authors:  G L Nicolson
Journal:  Cancer Metastasis Rev       Date:  1984       Impact factor: 9.264

Review 8.  Practical breast carcinoma cell kinetics: review and update.

Authors:  J S Meyer; R W McDivitt; K R Stone; M U Prey; W C Bauer
Journal:  Breast Cancer Res Treat       Date:  1984       Impact factor: 4.872

9.  Cytogenetic studies of human brain tumors and their clinical significance. 1. Medulloblastoma.

Authors:  F R Latimer; A A AlSaadi; T O Robbins
Journal:  J Neurooncol       Date:  1987       Impact factor: 4.130

10.  Flow cytometric analysis of human breast tumors and assessment of in vitro chemosensitivity by clonogenic assays.

Authors:  J Huot; J Aubin; F Goulet; R Goyette
Journal:  Cell Biol Toxicol       Date:  1990-01       Impact factor: 6.691

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.